Cancer glossary
SUVmax on a PET-CT report: what the number means, is there a normal
SUVmax is the highest FDG uptake in a lesion on PET-CT. Why this number has no universal normal value, what affects it and how it is compared over time.
Written and medically reviewed by
Dr. Tara EinullaevaMedical oncologist, 9 years in practice. Credentials · reviewed 17 October 2026
In short
SUVmax is the highest uptake value of the tracer (usually FDG, a radioactively labeled glucose) inside a lesion on a PET-CT scan. It measures how active the tissue is, not what it is: inflammation can also have a high SUVmax, and there is no line that separates “cancer” from “not cancer”.
How it appears in your report
Typical wording:
- “Mass in the left lower lobe with increased tracer uptake, SUVmax …” — the lesion takes up FDG more than the tissue around it; the maximum value is given at the end.
- “Hypermetabolic lymph node”, “FDG-avid” — the same idea in other words.
- “Uptake at the level of liver / blood pool background” — activity is compared with normal reference tissues.
- “Metabolically inactive” — the lesion is visible on CT but does not take up FDG.
- “SUVmax previously …, now …” — a comparison with an earlier scan.
What it means
SUV is the ratio of tracer concentration in the tissue to the injected dose adjusted for body weight. Several versions can be measured in one lesion:
| Measure | What it shows |
|---|---|
| SUVmax | The single “hottest” point inside the lesion |
| SUVmean | The average over the outlined area |
| SUVpeak / SULpeak | The average in a small volume of about 1 cm³ in the most active part; SUL is adjusted for lean body mass |
The number depends not only on the tumor but also on blood sugar, image noise, scanner resolution and how the area was outlined. That is why SUVmax values from different centers are not compared directly, and a single number without a description of the lesion says very little.
Does it affect treatment
SUVmax on its own does not change treatment. It helps show which lesions are active, choose a biopsy site and compare scans before and after treatment. For a formal assessment of response on PET-CT there are metabolic response criteria, PERCIST: they use SULpeak and require both a relative and an absolute change. What to do with a finding is decided by your treating doctor together with CT, pathology and examination findings. If you have several reports and are unsure what follows from them, I can review your documents in a consultation.
Questions to ask your doctor
- What exactly are we checking with this PET-CT, and how will the result affect the plan?
- Which scan was this compared with, and were the conditions comparable (center, scanner, blood sugar)?
- Do we need a biopsy of the active lesion to confirm what it is?
Sources
- Standard uptake value — Radiopaedia
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors — Wahl R.L. et al., Journal of Nuclear Medicine, 2009
- PET Response Criteria in Solid Tumors (PERCIST) — Radiopaedia
Watch me explain this on video
Short videos on my Instagram (in Russian)
FAQ
Related terms
This is reference information and not a substitute for medical advice. Your doctor interprets each value in the context of your whole situation.
